3,815
Views
8
CrossRef citations to date
0
Altmetric
Review Article

Access to hypertension care and services in primary health-care settings in Vietnam: a systematic narrative review of existing literature

ORCID Icon, , , , &
Article: 1610253 | Received 13 Aug 2018, Accepted 15 Apr 2019, Published online: 23 May 2019

ABSTRACT

Background: Health care in Vietnam is challenged by a high burden of hypertension (HTN). Since 2000, several interventions were implemented to manage HTN; it is not clear what is the status of patient access to HTN care.

Objective: This article aims to perform a systematic narrative review of the available evidence on access to HTN care and services in primary health-care settings in Vietnam.

Methods: Search engines were used to identify relevant records of scientific and grey literature. Data from selected articles were analysed using standardised spreadsheets and MaxQDA and following a framework synthesis methodology.

Results: There has been increasing interest in research and policy concerning the burden of HTN in Vietnam, covering many aspects of access to treatment at the primary health-care level. Vietnam’s National HTN Programme is managed as a vertical programme and its services integrated into the network of primary health-care facilities across the public sector in selected provinces. The Programme financed population-wide screening campaigns for the early detection of HTN among people above 40 years of age. There was no information on the acceptability of HTN health services, especially regarding the interaction between patients and health professionals. In general, articles reported good availability of medication, but problems in accessing them included: fragmentation and lack of consistency in prescribing medication between different levels and short timespans for dispensing medication at primary health-care facilities. There was limited information related to the cost and economic impact of HTN treatment. Treatment adherence among hypertensive patients based on four studies did not exceed 70%.

Conclusions: Although the Vietnamese health-care system has taken steps to accommodate some of the needs of HTN patients, it is crucial to scale-up interventions that allow for regular, systematic, and integrated care, especially at the lowest levels of care.

Responsible Editor Peter Byass, Umeå University, Sweden

Background

Rationale

The rise of non-communicable diseases (NCDs) and the continued burden of communicable diseases have caused a double burden on low- and middle-income countries (LMICs). According to the ‘Global Burden of Disease Study’ of 2017, NCDs comprised 73% of global deaths [Citation1], with a 40% increase in global ‘Disability-Adjusted Life Years’ [Citation2]. High systolic blood pressure was the main risk factor attributing to ‘Disability-Adjusted Life Years’ [Citation3]. For this reason, high or raised blood pressure, also called hypertension (HTN), is considered a global public health threat with significant economic and social impact [Citation1,Citation4]. At the same time, early detection, adequate treatment and good control of HTN are effective and cost-effective interventions to reduce disability, morbidity and mortality from HTN and its complications such as stroke, ischaemic heart diseases and kidney diseases [Citation1,Citation4Citation6].

In LMICs, ensuring access to quality HTN care for affected populations is a complex intervention that is better implemented through an integrated primary health-care approach. Such integrated intervention must consider the patient’s health needs for long-term care across time and disciplines which poses significant challenges to the weak health systems and constrained resources in LMICs [Citation4,Citation7].

In Vietnam, a recent Systematic Review and Meta-Analysis showed that the pooled prevalence of measured HTN (i.e. blood pressure ≥140/90 mmHg) was 21% ± 2.6, with lower estimates for the pooled prevalence of those aware of their HTN status (9%) and treated for HTN (5%); these three pooled estimates were significantly lower in rural settings [Citation8]. Since 2008, the Vietnamese Ministry of Health (MoH) implemented several interventions to prevent and manage HTN at the national, provincial, district and commune levels [Citation9]. What remains unclear is the status of patient access to HTN care and services across the primary health-care settings in the Vietnamese health system; synthesising the literature concerning such status would help policymakers and researchers to develop evidence-informed policies, formulate questions for further research, and share lessons learned from Vietnam’s experiences to improve HTN care in resource-constrained settings.

Objective

This article aims to perform a systematic narrative review of the evidence available in the literature on access to HTN care and services in primary health-care settings in Vietnam. Since this systematic narrative review focuses on the concept of access to care, it follows a framework synthesis methodology [Citation10] utilising the framework on people-centred access to health care proposed by Levenseque et al. [Citation11]. Such methodology is useful in building and consolidating knowledge by accommodating a large number of different types of studies [Citation10].

Context

The Socialist Republic of Vietnam is a lower-middle-income country with a population of over 90 million, of which 34% is urban [Citation12]. Vietnam has been experiencing demographic and epidemiological transitions. Life expectancy at birth was 76 years in 2016 [Citation13], with a remarkable decline in premature death and disability caused by most communicable, maternal, neonatal and nutritional causes [Citation14,Citation15].

The health-care system () comprises four levels providing preventive and curative services [Citation16,Citation17]. The commune health station (CHS) is the entry point of care, often comprising a doctor or assistant doctor, a midwife, nurses, an assistant pharmacist and a network of village health workers, and serves a population of 5,000–20,000; CHS team is responsible for providing preventive care programmes, managing common illnesses, providing health counselling, and referring advanced or severe illnesses [Citation16,Citation17]. At the district level, the ‘District Health Bureau’ provides administrative supervision to health services funded by ‘District People’s Committee’, while the ‘District Hospital’ is responsible for managing curative care and ‘District Preventive Medicine Centre’ manages preventive care [Citation16,Citation17]. In some provinces, the last two are integrated into one entity as the ‘District Health Centre’, while in other provinces they operate independently [Citation16,Citation17]. The district facilities provide technical support to the CHSs [Citation16,Citation17]. The commune and district levels are considered to be the grassroots level or the providers of primary health care in Vietnam. The ‘District Hospital’ offers the first referral level of in-patient care [Citation18]. The third level operates at each of the 63 provinces through a ‘Provincial Health Bureau’ or ‘Provincial Department of Health’ which oversees the district and provincial health services, in addition to private health-care facilities [Citation16,Citation17]. The provincial health services include curative care at one general and one or more specialised hospitals and preventive care at the ‘Provincial Preventive Medicine Centre’ [Citation16,Citation17]. The MoH has several departments, national research institutes and national or central hospitals (general and specialised) as the final referral level for therapeutic services [Citation16,Citation17].

Figure 1. Organisational chart of Vietnam’s health-care system, illustrating roles and responsibilities of each component

(adapted from the Ministry of Health).

Figure 1. Organisational chart of Vietnam’s health-care system, illustrating roles and responsibilities of each component(adapted from the Ministry of Health).

The MoH formulates national health policies and national target programmes (NTPs) on health, such as the expanded programme on immunisation and tuberculosis control, most of which are preventive; each NTP focuses on a disease or intervention and is a vertical programme [Citation16,Citation17]. A national hospital, institute or centre manages one NTP and works directly with provincial health entities, which in turn gives direction to district entities to implement the programme at the commune level [Citation16,Citation17]. Central and provincial governments are the primary funders for NTPs; a few of them receive international development assistance [Citation19]. In 2017, the Prime Minister’s office approved the NTPs on health and population for 2016–2020 with eight sub-projects, including the prevention of NCDs [Citation20,Citation21].

Following the adoption of the economic reform plan (i.e. Doi Moi) in 1986, fees were introduced at all levels of the public sector, so public funding covered only part of the medical costs; additionally, the private sector was legalised [Citation22]. Total health expenditure as a percentage of GDP has been consistent at roughly 6% since 2010. In 2014, total health expenditure accounted for 53% of general government expenditure and 46% as private health expenditure [Citation23]. Only 3% of total health expenditure was development assistance for health [Citation23]. Out-of-pocket spending accounted for 37% of total health expenditure and 80% of private health expenditure [Citation23].

The health insurance policy underwent successive changes as shown in , and recent changes are due to Vietnam’s commitment to achieving universal health coverage [Citation18]. Vietnam Social Security manages the health insurance programme and includes mandatory contributory insurance for formal employees and social health insurance for the rest of the population [Citation18,Citation24]. In 2015, enrolment in social health insurance became compulsory, and the premium was set at 5% of a salary or a minimum wage (~30 USD) [Citation18,Citation24]. For employees, the employer’s contribution is 60% of the total premium [Citation18,Citation24]. The government subsidised the premium for specific population groups, including 100% of the premium for the poor, ethnic minorities, and children under six years of age, at least 70% for the near-poor, and at least 30% for students [Citation18,Citation24]. The insurance coverage by December 2016 was 82% [Citation25].

Table 1. Timeline of health insurance and related-government decisions in Vietnam (1986–2016), including health insurance coverage and rate (when available).

Methods

The reporting of this review follows the ‘Preferred Reporting Items for Systematic Reviews and Meta-Analyses’ (PRISMA) statement [Citation26], as relevant to a narrative and descriptive analysis rather than a quantitative and statistical one.

Conceptual framework

This review uses the framework on people-centred access to health care proposed by Levenseque et al. [Citation11] to develop search terms, the analysis plan, and the synthesis of the results. Access and other related concepts such as accessibility, availability, and utilisation are usually used interchangeably [Citation27]. This article will use the definition of access as ‘the opportunity to identify health-care needs, to seek health-care services, to reach, to obtain or use health-care services and to actually have the need for services fulfilled’ [Citation11]. Levenseque et al. described access as a multidimensional concept resulting from the interaction between five dimensions of accessibility for the health system that provides or supplies care (namely, approachability, acceptability, availability and accommodation, affordability, and appropriateness) and five corresponding abilities of populations who demand care (namely, ability to perceive, ability to seek, ability to reach, ability to pay, and ability to engage) [Citation11]. These characteristics are defined in . For example, a person suffering from symptoms related to HTN (e.g. a continuous headache and nosebleeds) should be able to realise one’s health needs and act upon them by seeking health services in the public or private sector. Furthermore, people should be able to reach these health services (e.g. located nearby) and use them (e.g. pay for services without consequences). In turn, the health system should be ready to provide appropriate care to meet the patient’s needs (e.g. measure blood pressure to give the correct diagnosis and course of action).

Figure 2. Framework on people-centred access to health care with definitions and examples for each component, modified from Levenseque [Citation24].

Figure 2. Framework on people-centred access to health care with definitions and examples for each component, modified from Levenseque [Citation24].

Furthermore, Levenseque et al. argued that these characteristics are not independent, but they interact and influence each other differently during an episode of illness and care [Citation11]. For people living with HTN, their health-care needs include continuity of care defined as ‘the provision of coordinated care and services over time and across levels and disciplines, which is coherent with the patient’s health needs and personal circumstances’ [Citation28]. The need for continuity of care is reflected in the framework by examining the activation of the access process by an empowered patient beyond the first contact, as it is relevant each time the patient attempts to access care [Citation11].

Eligibility criteria

We developed eligibility criteria following the elements of population, concept, and context. The population under study are people living with HTN in Vietnam, which excludes Vietnamese refugees and migrants living abroad. The concept is the broad aspects of access to health care and services as defined by the conceptual framework. The context is settings which provide primary health care in Vietnam; this includes grassroots level (i.e. district and communal levels) and out-patient clinics at the provincial level, in addition to private clinics. The search included any existing scientific and grey literature; written in English; both quantitative and qualitative; with no limits to the type of study design, such as empirical studies, systematic reviews, meta-analyses, letters, guidelines and policy documents. The period under focus was 2000 until the search date (6 June 2017).

Information sources and search strategy

The following databases were searched: PubMed, EMBASE, CINAHL, and Web of Science, in addition to grey literature identified through Google, and the websites of WHO, other United Nations agencies, and the Vietnamese MoH. The search process included: (a) Initial limited search for one online database to analyse the text words contained in the title and abstract of retrieved records, and the index terms used to describe them; (b) Second search using all identified keywords and index terms across all included databases; and (c) Snowball retrieval of texts using the reference list of all identified records looking for additional ones. Detailed tables on the search terms used are provided in S1 Table.

Selection process

One researcher (LM) screened the title and abstract using the Rayyan QCRI application [Citation29]. Since one researcher was available to perform the selection process, a quality check was performed by two researchers (DE and MZ) independently cross-checking a random selection of 10 articles which resulted in full agreement over the screening results [Citation30]. Then, full texts were obtained and read to assess each record’s eligibility; this was conducted twice within one month to compare the results between readings at two separate time points [Citation30].

Data extraction

LM used a standardised spreadsheet to extract relevant data including author, publication year, objective, project of the study, data collection year, location, population and sampling, disease/s under investigation, relevant outcome measure/s, key findings, key discussion points, reported limitations, reported future steps, and reviewer’s notes on quality and relevance of the article. Then, articles were exported to MaxQDA and codded deductively based on themes identified by the conceptual framework, and inductively to add emerging themes. The use of inductive thematic analysis matches a more robust strategy of a single researcher conducting data extraction at two separate time points [Citation30].

Data analysis and synthesis

The process of framework synthesis included analysing and integrating the data within each theme and performing a cross-case synthesis for the included articles to compose the findings [Citation31]. This review aims to summarise qualitative and quantitative evidence narratively. Thus, quality assessment and heterogeneity were explored descriptively during data extraction, analysis and synthesis [Citation31]. Additionally, relevant policy documents and decisions written in Vietnamese were reviewed by TPLN for cross-checking and further explanations.

Results

Study selection

There were 2,280 records identified from the database search and 65 from the manual search (). Of these, 783 were duplicates, and 1,444 were excluded based on ‘title and abstract’ screening. The full texts of the remaining 118 records were examined, of which 26 peer-reviewed articles and 20 records of grey literature were included in this review. The grey literature included official documents published by the Vietnamese MoH and United Nations agencies, in addition to doctoral dissertations (note: five peer-reviewed articles used data from three doctoral dissertations).

Figure 3. Flow diagram for study selection process.

Figure 3. Flow diagram for study selection process.

Study characteristics

An overview of each article is presented in and divided as peer-reviewed articles and grey literature documents. Almost half of the studies investigated HTN as a primary outcome, while most of the system’s peer-reviewed articles and official documents had information on HTN as part of NCDs or their risk factors. For the 26 peer-reviewed articles, 13 (50%) described dimensions related to the accessibility for the health system [Citation32Citation44], 10 (39%) described dimensions related to the abilities of the population to access care [Citation45Citation54], and 3 (11%) on the MoH intervention to control HTN which described dimensions of both domains [Citation55Citation57]. The cross-sectional design was the most used one among peer-reviewed articles (n = 10; 39%), the majority of which looked at aspects of the abilities of the population (n = 7).

Table 2. Characteristics of included peer-reviewed articles.

Table 3. Characteristics of included grey literature documents.

shows a timeline for the selected records by their publication date. The number of records published increased over time, especially after 2010. In 2012, the number of records peaked (n = 11, 24%) and articles with a primary focus on HTN became more frequent. Geographically, data on study sites were available for 17 peer-reviewed articles (65%) and two doctoral dissertations unrepresented in peer-reviewed articles. Almost 75% of study sites were located in two northern regions of Vietnam. No individual study was conducted in Central Highlands.

Figure 4. Timeline for included studies and records by publication year, framework and type (n = 46) Population; ability of population. System; accessibility of system. MoH; Ministry of Health.

Figure 4. Timeline for included studies and records by publication year, framework and type (n = 46) Population; ability of population. System; accessibility of system. MoH; Ministry of Health.

Analytical framework and themes

Results are presented below under five main themes: one emerged theme on governance and policy, and four themes are based on the conceptual framework (i.e. perception of needs and desire for care, a merged theme for health-care seeking and reaching, health-care utilisation, and health-care consequences). For each theme, results are summarised under the relevant dimensions for accessibility for the health system and the abilities of the population to access care. Key findings of the conceptual framework are illustrated in .

Figure 5. Overview of key results on access to hypertension care at primary health care in Vietnam based on the framework on people-centred access to health care. HBP, high blood pressure; DHs, district hospitals; PHC, primary health care; CHS, commune health station.

Figure 5. Overview of key results on access to hypertension care at primary health care in Vietnam based on the framework on people-centred access to health care. HBP, high blood pressure; DHs, district hospitals; PHC, primary health care; CHS, commune health station.

Governance and policy

The National HTN Programme was established in 2008 as part of the NTP for the prevention and control of NCDs which contains five vertical or disease-specific projects for HTN, diabetes, cancer, asthma and chronic obstructive pulmonary diseases, and mental and neurological disorders. The National HTN Programme is managed by the Vietnam National Heart Institute at Bach Mai Hospital in Hanoi under the direction of the MoH; the primary objectives of this Programme for the period 2012–2015 can be summarised in two main categories [Citation9]:

  1. Promoting public knowledge about HTN. As part of these efforts, the government declared 15 May as a nationwide ‘Hypertension Day’, and created a local website to provide information and resources about HTN for both the public and health professionals [Citation22].

  2. Sustaining a model for HTN management at the grassroots level to treat patients according to guidelines. The National HTN Programme piloted the model at selected CHSs in 16 provinces, then expanded to 32 provinces, and finally to all provinces. The model included conducting population-wide screening for early detection at the commune level, and HTN being managed at CHSs with referrals as appropriate; additionally, health workers in implementing communes were trained on management and treatment of HTN [Citation22].

In 2015, 10% of communes nationwide implemented the HTN management model [Citation18], which did not cover all CHSs due to a reported lack of resources [Citation9,Citation58]. The National HTN Programme received funding in 2010, two years after its establishment [Citation9]. Since 2012, the NTP budget, which comes from central and provincial governments, has been declining [Citation18]. There has been limited external funding for NCD programmes [Citation9]. For example, one of the aims of the ‘United Nations’ One Plan’ (2013–2016) was to improve evidence on effective and efficient prevention and management of NCDs at national and sub-national levels [Citation59]; an independent review reported this goal to be only partially achieved due to lack of funding [Citation60].

In March 2015, the Government of Vietnam approved the national strategy for the prevention and control of NCDs for the 2015–2025 period; one of its goals is to scale up NCDs management models, including HTN, to cover 90% of health facilities at the primary level (i.e. district and commune) [Citation18]. However, according to the 2015 Joint Annual Health Review (JAHR), the ‘Strategy for the Protection, Care and Promotion of the People’s Health for the period 2011–2020ʹ, which is the roadmap used to create the goals of the five-year health-sector plan, remains focused mainly on infectious diseases [Citation18]. In general, most of the latest Vietnamese government documents and policies mention the challenges of both NCDs and infectious diseases as priorities for the health system [Citation18,Citation20,Citation61].

Perception of needs and desire for care

System’s approachability

Despite the increase in promotional activities to educate the public about NCDs and their risk factors, these prevention efforts remain ‘fragmented, lack professionalism, and have limited effectiveness’ [Citation62]. Both district and commune levels were sometimes engaged in conducting campaigns to reduce tobacco use, salt intake and alcohol consumption, and the district level considered more active than commune level. However, activities to promote physical exercise and sports were rare at any level [Citation34]; this was explained at the JAHR 2011 by the ‘lack of guidance for practice, appropriate methods, in addition to lack of practice facilities and sites’ [Citation62].

The National HTN Programme also supported and financed community-outreach campaigns following a population-wide screening model for the early detection of HTN among people aged 40 years and above; this model could not cover the entire population as it was organised periodically as a campaign at selected CHSs [Citation9,Citation34]. On the other hand, opportunistic screening, i.e. routine blood pressure check-ups during any patient’s visit to CHSs, is not yet integrated at the commune level due to underfunding [Citation9,Citation16]. Ideally, MoH and researchers recommended a combination of population-wide and opportunistic screening [Citation9,Citation35,Citation63].

Population’s ability to perceive

In Vietnam, the proportion of adults aged 18–69 years old who did not attend formal schooling or did not finish primary school was 17% according to a 2015 survey [Citation64]. Generally, there is still a lack of knowledge and awareness about HTN among the general population and patients, including risks, disease status, prevention, and management [Citation38,Citation45,Citation53,Citation65]. A 2013 survey on HTN-related knowledge found [Citation65] ‘a high level of basic knowledge, but a low level of specific HTN knowledge’. Furthermore, people with more basic knowledge about HTN were significantly found to be living in urban areas, better educated, had checked their blood pressure within a year, or had a previous diagnosis of HTN. The primary source of information reported was mass media (e.g. television, national/local radio, and newspapers).

People also have limited knowledge about lifestyle modifications to prevent and control HTN and its risk factors [Citation45,Citation48], and hypertensive patients were reported to have a pessimistic attitude towards such modifications [Citation53]. For example, a 2013 survey to detect HTN in Thai Nguyen asked participants if they ‘must have salt when eating’ [Citation48]. Among people with HTN, those unaware of their condition were less aware of the risks of salty food than patients aware of their disease; the adjusted odds ratio was not significant. Among people with HTN aware of their status, those treated were less informed about the risks associated with eating salty food than untreated patients (odds ratio = 2.7; 95% CI: 1.4–5.4), which means that being treated did not increase patients’ odds of knowing about the risks of eating salty food [Citation48].

Health-care seeking and reaching

The system’s acceptability, availability, and accommodation

There was no information on the acceptability of health services for HTN care and management, especially regarding the interaction between patients and providers. Information on the availability of resources in health centres has reported their limited capacity to provide care for HTN, especially in CHSs located closer to patients [Citation34,Citation62], and the contribution of the private sector was also described as limited [Citation34]. Patients, therefore, tended to bypass the commune level and go to more distant centres, which increases their costs [Citation34]; this impedes continuous support for disease management. Moreover, HTN management at district and commune levels is based mainly on measuring blood pressure and rarely takes into account behavioural or metabolic risk factors (e.g. smoking, total blood cholesterol, and the presence or absence of diabetes mellitus) [Citation9]. Three studies described the existing capacity of CHSs for NCDs, including HTN [Citation32Citation34] and three sub-themes emerged from the analysis of these studies: basic equipment, medication, and human resources.

A. Basic equipment

There is variation in the availability of basic equipment at different levels and sectors of the health system [Citation32,Citation33,Citation62]. The MoH regulations about required equipment in a CHS that has a doctor include a device to measure blood pressure (i.e. sphygmomanometer) and a simple biochemistry testing machine and urinalysis [Citation9]. A 2003 survey found that most CHSs had at least one functional sphygmomanometer with a stethoscope; however, the proportion of private clinics with either item was 63% and 73%, respectively [Citation32]. Furthermore, a capacity assessment conducted in one district in 2011 reported that essential blood and urine tests (i.e. blood glucometer, urine ketones test strips, and urine protein test strips) were not available in most CHSs, and patients had to be referred to higher levels or the private sector [Citation34].

B. Medication

Both public and private sectors had NCDs medication available [Citation32,Citation36]. shows a drug list for HTN control comparing drugs’ availability based on the MoH Health Insurance Drug Formulary and two assessments of CHSs [Citation9,Citation33,Citation34]. The table shows that three types of HTN medication were intermittently available at CHSs: ACE inhibitors, calcium channel blockers, and thiazide diuretics, in addition to aspirin. Although beta-blockers, loop diuretics, and statins might be available in some CHSs, health insurance does not cover them at commune level.

Table 4. Availability of selected essential hypertension (oral) medication based on health insurance drug formulary and two studies that investigated capacity of commune health centres.

Patients seeking medication in the public sector faced two problems. First, there is fragmentation and lack of consistency in prescribing medication between different levels [Citation9]. For example, doctors at higher levels may prescribe newer-generation medication that is not covered by health insurance at CHSs; if the patients want to keep using the same medication, they have to return to the higher-level facilities or purchase them at their own expense [Citation9]. While most basic HTN medication is cheap, newer generations may be less affordable [Citation32,Citation36]. Second, current regulations, according to JAHR 2014, allow provincial facilities to dispense HTN medication for 15 days, district facilities for 7–10 days, and CHSs for 5–7 days [Citation9]; in practice, provincial and district hospitals dispense HTN medication for 30–45 days. These short periods of prescribed medication require more visits to health facilities, which increases the treatment cost for patients, reduces their compliance, and decreases the odds of HTN control.

C. Human resources

In the public sector, there are different types of health worker at CHSs, including doctors, midwives, assistant physicians, an assistant pharmacist and nurses [Citation32,Citation34]. In the private sector, one commune’s assessment showed that 11% of those working at private clinics had no official medical qualifications or certificates, and approximately 80% are practising without registration [Citation32]. Traditional practitioners and pharmacists accounted for 20% of the private workforce; also, almost 37% of CHS staff had a private practice [Citation32].

The level of clinical knowledge about HTN management is limited in both public and private sectors [Citation16,Citation32]. One assessment from 2003 asked providers ‘what questions they would raise with a 58-year-old man presenting with high blood pressure?’, then calculated a score for each provider as the percentage of mentioned items out of 11 expected correct answers. Most respondents scored poorly; only two public providers could specify ≥70% of correct answers, while other providers identified <50%, including 70% of public providers (n = 30), 80% of private–public (n = 53), and 90% of private providers (n = 129) [Citation32]. Another survey from 2012 showed that the proportion of CHSs staff who knew how to diagnose HTN was 51%; while in a self-assessment survey among newly qualified doctors, only 38% could monitor and manage chronic diseases in the community [Citation66].

Several opportunities are still ongoing to train health workers at district and commune levels on the prevention and management of HTN [Citation39Citation41]. For example, the MoH Decision number 1816, dated 2008, stated the responsibility of staff from higher-level facilities to support staff from lower-level facilities by providing in-service training [Citation19]. Also, the National HTN Programme conducted training of trainers for doctors from all provinces; these provincial trainers then taught medical or nursing staff at the district and commune levels; however, in most provinces, the training has not yet covered all centres [Citation9]. Village health workers had limited access to training, although they were reported to be involved in the early detection and monitoring of HTN cases [Citation34]. Available details about training projects are in S2 Table.

Population’s ability to seek and reach health care

Findings from different surveys showed a low level of HTN awareness and treatment. For example, the latest national survey on risk factors for NCDs reported that 30% of the study population aged between 18 and 69 years had never had their blood pressure measured by any health worker [Citation67]. Higher odds of people with HTN being aware of their disease status were reported among women [Citation46Citation48,Citation67], the oldest age group [Citation46,Citation48,Citation67], a higher level of education [Citation46,Citation48] and having a family history of HTN [Citation46]. The prevalence of treatment among HTN patients according to five studies ranged between 12% and 30% [Citation46Citation48,Citation50,Citation67]; the treatment prevalence was higher among those aware of their condition [Citation46,Citation48,Citation50]. Higher odds of treatment were found among men [Citation63], urban residents [Citation46,Citation47], a lower level of education, and having a family history of HTN [Citation46]. According to one study, people of ethnic minorities were more likely to be aware of their HTN status and less likely to be on treatment [Citation48].

Only 14% of people with HTN reported having their disease managed at a health facility according to the 2015 national survey on risk factors for NCDs [Citation67]. Patients often described the resources at the CHSs or public sector in general as sub-standard [Citation38,Citation53], and the top three health-care levels sought and reached were district level (34%), provincial level (27%), and CHSs (19%) [Citation67]. Other reported options were central hospitals, the private sector, traditional healers, and self-treatment [Citation65,Citation67]. However, there was not enough information in the literature regarding the use of private clinics, traditional healers, drug stores and pharmacies.

Health-care utilisation

System’s affordability

There is limited information related to the cost and economic impact of treating HTN. No economic evaluation was performed for the MoH intervention, although the manager reported in a review that patients continued to pay for the medicines out of their own pockets after the end of the funding for HTN medicines [Citation57]. One study estimated the cost of HTN treatment at the CHS level to be 70.8 USD per person per year, almost 6 USD per person per month [Citation68]. On the other hand, a simulation model estimated that scaling up an HTN programme to cover 80% of patients could avert 266,000 deaths over the period 2005–2006 [Citation35]. Such a programme would include providing treatment for high-risk individuals with aspirin and drugs to lower blood pressure and cholesterol; this treatment, in turn, would reduce disease progression, prevent complications such as heart attacks and strokes, and reduce complication expenses [Citation35]. It is unclear if such a scaling up is possible given the continuous cuts in government funding for the National HTN Programme. The funding for the NCDs programme was cut by 68% in 2014 compared to 2013 [Citation9]. In 2013, the total funds for NTPs accounted for nearly 70 million USD, of which 13% was allocated to the NCDs programme, and only 17% of NCDs programme funds went for HTN (nearly 1.5 million USD). At the grassroots level, there is no budget allocated explicitly for the prevention, management and treatment of NCDs [Citation18,Citation33,Citation34]; the primary sources of funding for each district are the state budget through the Provincial Department of Health, user fees and health insurance based on a fee-for-service model [Citation34]. While CHSs should receive a minimum of 10% of the health insurance fund allocated to the district level, they were often allocated precisely this amount, which was not enough to meet the cost of medical needs for people with NCDs at the commune level [Citation9].

There are different types of health insurance coverage. Some patients may have 100% coverage for all health services, and others may have a 20% co-payment [Citation22]. One of the goals of the Law on Health Insurance was to create a mechanism for CHSs and district facilities to provide primary medical services and to make them more accessible to people at the grassroots [Citation66]. The 2014 revision of the Law on Health Insurance states that only curative care services can be reimbursed, such as patients who have symptoms and visit health facilities to get their blood pressure measured and medication in line with the MoH Health Insurance Drug Formulary; however, no preventive care services are covered, including population-based screening for early detection [Citation9]. Subsequent implementation guidelines have not specified details for HTN care, such as a list of interventions covered by the health insurance fund [Citation18]. In 2015, the MoH published a roadmap towards developing and implementing a basic health service package paid by health insurance in Vietnam [Citation61], a pilot study for which is ongoing.

For years, health insurance did not reimburse types of HTN medication included in the National HTN Programme budget (e.g. beta blockers), even if the programme’s distribution was limited. The cuts to the national fund for NCD programmes have further reduced its ability to procure required medical supplies; however, the health insurance policy was not adjusted to compensate for this reduction, and patients needed to pay for their medication [Citation9,Citation57]. In such cases, patients might not purchase medication or even a full or regular dose [Citation19].

Furthermore, the limited scope of services and medication available and covered by the health insurance scheme at the CHS level have in many cases caused patients to bypass the CHSs to higher levels [Citation34]. At the district level, NCD patients who have health insurance received free treatment provided that CHSs referred them; patients who have insurance but who bypass the CHSs have to pay for full treatment costs [Citation34]. Patients might even bypass the entire primary health-care system to the secondary level (i.e. provincial hospitals); this leads to higher out-of-pocket payments through direct and indirect costs (e.g. co-payments that are higher at secondary and tertiary facilities and costs of transport and accommodation) [Citation40,Citation66].

Population’s ability to pay

There was limited information about the association of HTN management with economic or working status. One article reported a higher risk of being hypertensive among wealthier men and poorer women [Citation35,Citation69]. However, there was a non-significant association between having health insurance and a patient’s ability to follow treatment; the MoH found that hypertensive subjects without insurance did not join its intervention (odds ratio = 1.4; 95% Confidence Interval is 0.8–2.4) [Citation55].

There is no specific information on health expenditure for HTN. However, hypertensive subjects mentioned financial barriers to obtaining care, including financial stress and confusion about changes in the insurance scheme [Citation53]. On the other hand, some financial information was available for a general category of chronic diseases or NCDs showing catastrophic health expenditure for most households [Citation34,Citation35]; these information includes diseases such as cancer with expensive treatments and is not appropriate estimations when discussing HTN.

Health-care consequences

System’s appropriateness

The National HTN Programme/MoH issued the protocol for diagnosis and treatment of HTN in 2010 and disseminated it widely [Citation9]. The latest version of this protocol was approved in 2013. However, at CHSs, the HTN protocols, the WHO/International Society for HTN risk prediction charts, and other essential guidelines for health education and counselling on risk factors and early detection of NCDs were either unavailable or underused [Citation34]. Also, health facilities could apply other local guidelines only if they were published officially, for example, the annual recommendations of Vietnam Association of Cardiology regarding the treatment options for hypertensive subjects based on the stage of their disease [Citation37,Citation70]. The main difference between these two documents was in the level of detail in the information presented, with no conflict in their contents.

There is not enough information to evaluate the appropriateness of treatment decisions and services provided by the health system. One study investigated the nature of treatment for HTN patients [Citation47] and reported that the vast majority of those aware of their HTN (n = 212, 91%) had been recommended to modify their behaviour (e.g. taking exercise, reducing sodium or salt intake, giving up smoking, or losing weight). Besides, the most common medication used by 60% of the hypertensive subjects included calcium channel blockers (n = 54; 59%) and ACE inhibitors (n = 36; 39%).

Most articles discussing hypertension have recommended the need to implement both a population-wide strategy (e.g. salt reduction) and a patient-focused clinical or behavioural strategy to treat HTN and avoid its complications [Citation35,Citation42Citation46,Citation50,Citation56]; these included two interventions: the MoH intervention and Eat Less Salt intervention [Citation42,Citation56]. Both interventions included healthy lifestyle campaigns promoting behavioural change to lower blood pressure and improve HTN control [Citation42,Citation56]. The results from both interventions showed a significant reduction in systolic and diastolic blood pressure and a less salty diet in the general population [Citation42,Citation56]. However, the MoH intervention reported limited effects on smoking and alcohol consumption [Citation56].

Lack of continuity in the health system was extensively reported as a significant barrier to accessing high quality and affordable medical services, especially for chronic diseases. Many factors contribute to this lack of continuity. For example, at the administrative level, there is a separation between curative and preventive services, especially at the district level. This separation is more pronounced in the provinces that followed the MoH Decree in 2008 on splitting the District Health Centre, which provided integrated curative and preventive services and directly managed CHSs in two different entities (i.e. District Hospital and District Preventive Medicine Centre) [Citation71]. Additionally, at the clinical level, patients face discontinuity in their medical information and treatment process between levels, facilities, and even from one treatment episode to another, given the lack of organised referral/back-referral system to track their progress [Citation19]. Besides, providers at higher level hospitals often practise overprovision of curative care services leading to an increased disconnect between levels [Citation18]. Mendis’ assessment reported that using multidisciplinary teams was not feasible or affordable at CHSs level, and there was no organised appointment/reminder system for people with HTN to come for follow-up [Citation33]. However, in Dong Hy district’s assessment, communes within the WHO project or national NCD programme (n = 7/18) mentioned implementing active and continuous management and treatment of HTN, with no details about the mechanism used to provide long-term management and continuity of care [Citation34]. To facilitate information sharing, a software package to manage records of hypertensive subjects was established in 36 provinces across the health system’s levels and facilities, in which health workers can enter hypertensive patients’ information after each visit to the CHS. However, data extracted are used only to send reports to a higher level of care, and health insurance for reimbursement, and not for treatment follow-up [Citation9].

Population’s ability to engage

Relevant findings included information on the prevalence of HTN control, treatment adherence, and quality of life; there was no specific information on self-care or self-management practices. There was a low prevalence of hypertensive patients with controlled blood pressure; the prevalence ranged between 3% and 16% [Citation46Citation48,Citation50,Citation67]. Among treated patients, nearly a third had controlled blood pressure [Citation46,Citation48,Citation50]. The gap between the prevalence of HTN and the prevalence of treatment and control persisted between 2001 and 2009 even though the prevalence of treatment and control have increased significantly over time; this meant that a high proportion of people with HTN were undiagnosed or untreated, which could result in higher stroke-related mortality [Citation54]. Higher odds of control were found among younger women and married individuals [Citation46].

The prevalence of treatment adherence among hypertensive patients based on four studies did not exceed 70% and was even less than 50% in a one cohort study [Citation44,Citation49,Citation52,Citation55]; however, the definition of adherence differed across the studies (see S4 Table). Programme compliance in the MoH intervention with three-year follow-up was independently associated with changes in systolic or diastolic blood pressure measurements and the number of anti-hypertensive drugs prescribed [Citation55]. The head of the programme reported that continuous follow-up and management encouraged patients to continue taking the medicines, even after the end of the funding [Citation57]. The cohort study [Citation52] used a qualitative inquiry to further investigate the reasons for adherence and non-adherence among selected patients. In many cases, patients classified as non-adherent in a quantitative analysis of facility-based data mentioned during interviews that they tend to buy their medicines from pharmacies rather than getting them from the CHS. The main factors leading to good adherence were either awareness of possible complications of high blood pressure or experience of such complications within a patient’s family. The two main reasons for not taking HTN medication were forgetting or experiencing side-effects. Also, two patients actively decided not to take the pills when they felt better.

Finally, two studies measured the quality of life among hypertensive subjects using different scales [Citation49,Citation51]; however, they identified similar factors associated with a lower score of quality of life, including older patients, women, and those with co-morbidities. An intervention study investigated the effect of Tai Chi exercise programme on the health of older adults including their quality of life; findings showed that the intervention group had a significant improvement in their perceived health, which remained for at least eight weeks after training ended [Citation43].

Discussion

There has been increased interest in research and policy concerning the burden of HTN in Vietnam, which covered many aspects of access to HTN care at the primary health-care level. In general, Vietnam’s National HTN Programme is managed as a vertical programme with its services integrated into the public network of primary health-care facilities in selected provinces [Citation72]. The scale-up of the National HTN Programme has occurred gradually; however, fewer than half of CHSs have implemented activities for HTN [Citation25]. Also, the programme is facing continuous budget cuts. While the treatment of HTN is integrated into the primary health-care services, there is still a lack of integration between levels of care and with other vertical programmes for NCDs which share similar risk factors and their long-term nature. Collaborative efforts with different policy sectors (such as national NCDs programmes, preventive programmes and the insurance programme) are needed to overcome barriers to prevention and control services for NCDs including HTN at the health-care system, health-care provider and patient levels [Citation73]; these efforts should take into account the context of Vietnamese society and its health system. Many barriers in access to HTN care are similar to what is reported in other international studies and settings, such as low patient health literacy; overburdened health-care providers; the lack of an organisational structure to accommodate a non-physician as a primary care provider; the lack of confidence and/or policy towards the non-physician providers’ ability to manage uncomplicated and stable patients; the lack of infrastructure for data collection and monitoring of clinical information on a periodic basis; and finally, limited resources [Citation73,Citation74]. Generally, new policies need to leverage existing resources with limited ones assigned for overall health care and NCDs. Our discussion will focus on a number of key aspects: (1) screening; (2) acceptability; (3) accommodation of medication and treatment guidelines; (4) health-care use; (5) long-term nature of HTN disease and care including adherence, self-management and quality of care; (6) task shifting; and (7) the role of the private health sector.

First, population-wide screening has been essential to the National HTN Programme strategy for prevention and control of HTN. A review of systematic reviews published in 2015 found insufficient evidence to confirm a beneficial effect of blanket screening for HTN and/or diabetes in LMICs compared to other types of screening methods; the authors urged caution regarding the implementation of population-based mass screening, which mobilises scarce resources without adequate evidence of its effects [Citation75]. Studies from Vietnam mentioned the importance of population-wide screening in both health promotion and secondary prevention, but also called for including opportunistic check-ups for high-risk groups at all health facilities. A policy statement made by the World HTN League called for implementing systematic approaches to the screening of blood pressure by having a routine assessment at each clinical encounter, regardless of the complaints that led the patient to visit the clinic [Citation76]. An analysis of data on persons aged 50 years or older from six LMICs estimated that just one year of routine opportunistic HTN screening during formal visits to health-care providers could yield significant increases in HTN awareness among older people in developing countries; this opportunistic screening added the advantage of leveraging existing resources and infrastructure, as well as facilitating a direct transition from the point of diagnosis to subsequent expert counselling and clinical care for newly identified HTN patients [Citation77]. At the same time, the effectiveness of all screening programmes (i.e. community-outreach or opportunistic during clinic visits) depends on having a proper mechanism to refer people with high blood pressure for further diagnosis and management [Citation76Citation78].

Second, research from other countries identified acceptability as an essential factor for access to HTN care. Case studies from South Africa on barriers to health care for the chronically ill reported that the necessary elements for strengthening the public sector not only require better drug supply chains, ambulance services, referral systems and clinical capacity and addressing the financial barriers, but also need to consider how providers can engage with patients to strengthen the therapeutic alliance [Citation79].

Third, results have shown the limited accommodation of HTN medication at the primary health-care level in Vietnam, in addition to patients’ confusion regarding whether and how the costs of the medication are covered by health insurance. Patients reported using alternative sources for medication such as private drug stores and pharmacies; however, there is no specific information on accessibility to these alternative sources, especially on out-of-pocket expenditures. Participants in a study to explore individual and community preferences for a health benefit package among the uninsured in Vietnam identified both costly services that are seldom used (e.g. in-patient care) and less costly services used on a frequent basis (e.g. drugs and out-patient care) as a priority in the design of any health benefit package; the participants justified their wish to cover prescribed medication through health insurance because of the cost associated with this benefit and its vital role in treatment [Citation80]. WHO’s recommendations for HTN care in low-resource settings include the availability of a core set of essential anti-hypertensive medication in primary health-care facilities that have a doctor on the staff: thiazide diuretic, calcium channel blocker (amlodipine), beta-blocker (atenolol), and angiotensin inhibitor (enalapril), in addition to medication used in presence of other risk factors for cardio-vascular condition or strokes, for example, statin (simvastatin) and aspirin [Citation7]. Furthermore, policies must consider each patient’s need for continuous access to these medications with a reasonable timespan for their repeated visits to the health services. Although Vietnam has standardised treatment guidelines, they should be contextualised and aligned with the health insurance policy and the availability of medication at different levels of care.

Fourth, there is scarce evidence regarding the nature of the use of HTN care and services in Vietnam. People mentioned being confused about the health insurance scheme. These results are similar to a survey from 2011 on public knowledge and understanding of health insurance schemes and their benefits, in which 30% of heads of household did not know about health insurance, and 92% did not know or gave the wrong answer for the premium rate [Citation81]. However, there is no information on out-of-pocket payments for HTN care, especially given that many patients reported buying medication from private pharmacies. Available data for a general category of NCDs found that people with chronic conditions spend 19% more on out-patient services than those with other health conditions [Citation82]. Further analysis should consider the impact of repeated visits to lower and higher levels of care, which are expected to cause extra costs.

Fifth, as LMICs are facing an emerging burden of NCDs, there are increased global calls on the role of strengthening primary health care and ensuring universal health coverage in their prevention and control, especially to achieve a challenging need for NCDs patients represented by the continuity of care [Citation83Citation85]. Continuity of care is aimed to provide patients with coherent life-long care in three essential dimensions: longitudinal care, the nature of the patient–provider relationship, and coordinated care across levels and disciplines [Citation86]. Given that many LMICs, especially in sub-Saharan Africa, have experienced continuity of care through HIV programmes, many practical examples of successful HIV interventions were proposed for possible extension to NCDs such as care delivered with a family focus; paper-based or electronic appointment systems for scheduled follow-up; on-site medical records; mobile phone applications or SMS reminders; use of peer educators and patient groups for counselling and adherence support; standardised treatment protocols; and task shifting and task sharing [Citation87,Citation88]. Such interventions must be considered by research and policy to establish and strengthen the continuity of care that can promote patients’ adherence to treatment and build their skills in self-management and self-care, which eventually help in achieving better health outcomes.

Sixth, recent evidence stressed the effectiveness, cost-effectiveness, and efficiency of task-shifting interventions at primary health-care facilities, including community health workers [Citation74,Citation89,Citation90]. The success of such interventions is likely to depend on context (e.g. demographic factors and the characteristics of community or village health workers, care settings, and training programmes). Policy and research should, therefore, focus on the possibility of contextualising task-shifting interventions in Vietnam’s health system.

Seventh, questions have been raised regarding the role of drug stores and pharmacies in access to medication, and subsequently, adherence to treatment, as an additional option to leverage all existing resources towards better HTN care. For example, research from Tanzania looked at the feasibility and acceptability of screening for HTN in private drug retail outlets [Citation91] and found that out of 971 customers, only one refused to be screened. However, only 20% of those newly diagnosed visited the referral clinic within two weeks. Another qualitative study from Indonesia looked at the role of community pharmacists in the management of chronic NCDs [Citation92]. The findings described a positive impact on the regular interactions between patients and community pharmacists as their care providers driven by mutual recognition of each other’s roles and their ability to communicate. However, the research called for systematic support from different stakeholders to improve the primary care practice of community pharmacists towards further continuity of care. Vietnam could also investigate and build on the role of the private health sector, including clinics, pharmacies, drug stores, and traditional medicine practitioners.

Finally, essential information is needed to craft evidence-based policies towards facilitating access to HTN care in Vietnam; information about the impact of key social determinants of health (e.g. ethnicity), perception of needs and desire for care (i.e. acceptability of services and the ability of the population to seek and reach care), including the patient’s attitude towards providers and available care, in addition to the provider’s motivation to care for patients, especially for those in need of long-term care as hypertensive patients are. Other critical factors are the development of a basic benefits package for health insurance, in addition to assessing health-care use specifically for HTN patients and dimensions of the continuity of care (e.g. longitudinal care and coordinated care including information management). Some aspects of access and continuity of care need further qualitative research, such as the interaction and nature of the relationship between patients and providers.

Limitations

First, our literature search has not explicitly incorporated information available only in the Vietnamese language such as articles published in Vietnamese journals, or doctorate and master’s theses written for Vietnamese Universities. However, JAHR is expected to include most good-quality studies published in Vietnamese and we incorporated official documents in their original language. As a next step, it is important to conduct a separate review into Vietnamese literature which also aims to investigate the differences and similarities between such articles and those published in international journals in terms of both methods and results. Second, we did not undertake a full quality assessment of the identified articles since our review included all eligible articles rather than focusing on a subset of studies. Yet, the subsequent analysis of included articles and official documents found no contradictory results or information [Citation93].

Conclusion

Although the Vietnamese health-care system has taken steps to accommodate some of the needs of HTN patients, it is crucial to scale-up interventions that allow for regular, systematic, and integrated care, especially at the lowest levels of care. Therefore, a system to allow the commune level to properly receive back-referred patients and monitor stable ones should be established and strengthened; such asystem is vital to facilitate patients’ adherence to treatmentand continuity of care. Also, this monitoring systemshould be supported with appropriate resource allocations which in turn strengthen approaches for primary health care and universal health coverage.

Author contributions

LM conceived, designed, undertook the review, and wrote the initial draft. TPLN supported synthesis and interpretation of results, in addition to language translation. All authors contributed to the revisions and approved the final manuscript.

Ethics and consent

Not required.

Paper context

In limited-resources settings, health systems are facing an increased burden of chronic conditions (for example, hypertension in Vietnam). Vietnam is facing a high burden of hypertension. Services to patients are integrated into primary health-care network. Despite progress, challenges arise with the system’s approachability, accommodation, and appropriateness. People need support in perceiving health needs, seeking, reaching and engaging with care. Commune levels need further support to provide regular and systematic care and follow-up to stable patients.

Supplemental material

Supplemental Material

Download Zip (231.2 KB)

Acknowledgments

The authors would like to thank Hans Ket from VrijeUniversiteit Library, for his assistance and guidance in refining the search strategy and modifying it to fit the parameters of the various databases. The authors would also like to thank Onaedo Ilozumba, Esther van Adrichem and Dr Pham Dung for their comments on an earlier version. Deborah Eade provided editing assistance.

Disclosure statement

No potential conflict of interest was reported by the authors.

Supplementary Materials

Supplemental data for this article can be accessed here.

Additional information

Funding

The Erasmus Mundus Joint Doctorate Fellowship [Specific Grant Agreement 2014–0681], of which LM is a beneficiary, supported this review. The funding agency had no role in study design, analysis, or preparation of the manuscript.

References

  • Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–21.
  • Kyu HH, Abate D, Abate KH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1859–1922.
  • Stanaway JD, Afshin A, Gakidou E, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1923–1994.
  • WHO. A global brief on hypertension: silent killer, global public health crisis [Internet]. Geneva: World Health Organization; 2013. Available from: http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/
  • Johnson CO, Nguyen M, Roth GA, et al. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. Internet]. 2019 [cited 2019 Mar 16]. Available from: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(19)30034-1/abstract
  • The GBD 2016 Lifetime Risk of Stroke Collaborators. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016. N Engl J Med. 2018;379:2429–2437.
  • WHO. Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings [Internet]. Geneva: World Health Organization; 2010. Available from: http://www.who.int/nmh/publications/essential_ncd_interventions_lr_settings.pdf
  • Meiqari L, Essink D, Wright P, et al. Prevalence of Hypertension in Vietnam: A Systematic Review and Meta-Analysis. Asia Pac J Public Health. 2019;31: 101–112. 1010539518824810.
  • Joint Annual Health Review. 2014: strengthening Prevention and Control of Non-communicable Diseases. Hanoi: Vietnam Ministry of Health & Health Partnership Group; 2014.
  • Snilstveit B, Oliver S, Vojtkova M. Narrative approaches to systematic review and synthesis of evidence for international development policy and practice. J Dev Eff. 2012;4:409–429.
  • Levesque J-F, Harris MF, Russell G. Patient-centred access to health care: conceptualising access at the interface of health systems and populations. Int J Equity Health. 2013;12:18.
  • Population and employment: average population by residence. Stat. Handb. Vietnam [Internet]. Internet: General Statistics Office of Viet Nam; 2015. Available from: https://www.gso.gov.vn/default_en.aspx?tabid=515&idmid=5&ItemID=16052
  • The World Bank. Life expectancy at birth, total (years) [Internet]. World Bank DataBank. 2018 [cited 2018 Apr 22]. Available from: https://data.worldbank.org/indicator/SP.DYN.LE00.IN.
  • Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Database (GBD) Compare Data Visualization [Internet]. Seattle, WA: IHME, University of Washington; 2016. cited 2018 Apr 22. Available from: http://vizhub.healthdata.org/gbd-compare.
  • Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2010, Country Profile: vietnam [Internet]. Seattle, WA: IHME, University of Washington; 2013 cited 2016 Jun 30. Available from: http://www.healthdata.org/sites/default/files/files/country_profiles/GBD/ihme_gbd_country_report_vietnam.pdf
  • Joint Annual Health Review 2017. Hanoi: Vietnam Ministry of Health & Health Partnership Group; 2007.
  • WHO, Vietnam MoH. Health Service Delivery Profile, Viet Nam [Internet]. World Health Organization & Vietnam Ministry of Health; 2012. Available from: http://www.wpro.who.int/health_services/service_delivery_profile_vietnam.pdf
  • Joint Annual Health Review. 2015: strengthening Primary Health Care at the Grassroots Towards Universal Health Coverage. Hanoi: Vietnam Ministry of Health & Health Partnership Group; 2016.
  • Joint Annual Health Review. 2010: vietnam’s Health System on the Threshold of the Five-year Plan 2011–2015. Hanoi: Vietnam Ministry of Health & Health Partnership Group; 2010.
  • Five-year Plan: for people’s health protection, care and promotion in the period 2016–2020 [Internet]. Vietnam Ministry of Health; 2016. Available from: http://www.euhf.vn/upload/Strategic%20documents/82.%20MOH%205-year%20plan%20(Eng).pdf
  • PM approves national health target programme. Voice Vietnam VOV [Internet]. 2017; Available from: http://english.vov.vn/society/pm-approves-national-health-target-programme-355750.vov
  • Duong DB Understanding the Service Availability for Non-Communicable Disease Prevention and Control at Public Primary Care Centers in Northern Vietnam [Internet]. Harvard Medical School; 2015. Available from: https://dash.harvard.edu/handle/1/15821581
  • WHO. Global Health Expenditure Database, NHA indicators [Internet]. 2014. Available from: http://apps.who.int/nha/database/Select/Indicators/en
  • Hoang TP, Tran TMO. 2016. Strategic Purchasing for Universal Health Coverage: social Health Insurance Fund in Vietnam [Internet]. Vietnam: Health Strategy and Policy Institute. Available from: http://resyst.lshtm.ac.uk/resources/strategic-purchasing-universal-health-coverage-social-health-insurance-fund-vietnam
  • Joint Annual Health Review. 2016: towards healthy aging in Vietnam. Hanoi: Vietnam Ministry of Health & Health Partnership Group; 2018.
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.
  • McIntyre D, Thiede M, Birch S. Access as a policy-relevant concept in low- and middle-income countries. Health Econ Policy Law. 2009;4:179–193.
  • Meiqari L, Al-Oudat T, Essink D, et al. How have researchers defined and used the concept of ‘continuity of care’ for chronic conditions in the context of resource-constrained settings? A scoping review of existing literature and a proposed conceptual framework. Health Res Policy Syst. 2019;17:27.
  • Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan – a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.
  • Bown MJ, Sutton AJ. Quality control in systematic reviews and meta-analyses. Eur J Vasc Endovasc Surg. 2010;40:669–677.
  • Petticrew M, Roberts H. Systematic reviews in the social sciences: a practical guide. Malden, MA: Blackwell Publishing; 2006.
  • Tuan T, Dung VTM, Neu I, et al. Comparative quality of private and public health services in rural Vietnam. Health Policy Plan. 2005;20:319–327.
  • Mendis S, Al Bashir I, Dissanayake L, et al. Gaps in Capacity in Primary Care in Low-Resource Settings for Implementation of Essential Noncommunicable Disease Interventions. Int J Hypertens. 2012;2012:584041.
  • Hoang VM, Do YK, Bautista MAC, et al. Describing the primary care system capacity for the prevention and management of non-communicable diseases in rural Vietnam. Int J Health Plann Manage. 2014;29:E159–E173.
  • Hoang VM, Lan Huong D, Bao Giang K, et al. Economic aspects of chronic diseases in Vietnam. Glob Health Action. 2009;2:1965.
  • Alwan A, MacLean DR, Riley LM, et al. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet. 2010;376:1861–1868.
  • Abdul Rahman AR, Reyes EB, Sritara P, et al. Combination therapy in hypertension: an Asia-Pacific consensus viewpoint. Curr Med Res Opin. 2015;31:865–874.
  • Barzin Y. The role of NGOs in rural Vietnam: a case study and critique. BMC Proc. 2012;6.
  • Sundberg C, Wallin H, Hellenius M, et al. Physical activity on prescription; an education and training program for healthcare practitioners in Vietnam. J Sci Med Sport. 2012;15:S349–S350.
  • Islam SMS, Purnat TD, Phuong NTA, et al. Non Communicable Diseases (NCDs) in developing countries: A symposium report. Glob Health. 10. 2014;10:81.
  • Markuns J, Goldman L, Cummings S, et al. Primary care development in Southeast Asia: building an essential foundation for health systems. Ann Glob Health. 2015;81:161.
  • Do HTP, Santos JA, Trieu K, et al. Effectiveness of a Communication for Behavioral Impact (COMBI) Intervention to Reduce Salt Intake in a Vietnamese Province Based on Estimations From Spot Urine Samples. J Clin Hypertens. 2016;18:1135–1142.
  • Nguyen MH, Kruse A. The effects of Tai Chi training on physical fitness, perceived health, and blood pressure in elderly Vietnamese. Open Access J Sports Med. 2012;3:7–16.
  • Nguyen HL, Allison JJ, Ha DA, et al. Culturally adaptive storytelling intervention versus didactic intervention to improve hypertension control in Vietnam: a cluster-randomized controlled feasibility trial. Pilot Feasibility Stud. 2017;3:22.
  • Duong D, Ryan R, Vo D, et al. Hypertension screening and cardiovascular risk profiling in Vietnam. Nurs Health Sci. 2003;5:269–273.
  • Son PT, Quang NN, Viet NL, et al. Prevalence, awareness, treatment and control of hypertension in Vietnam-results from a national survey. J Hum Hypertens. 2012;26:268–280.
  • Boas ZP, Fitzpatrick AL, Ngo QV, et al. Abstract MP043: awareness of Hypertension and Determinants of Treatment in a Community-Based Observational Sample in Da Nang, Viet Nam. Circulation. 2012;125:AMP043–AMP043.
  • Ha DA, Goldberg RJ, Allison JJ, et al. Prevalence, Awareness, Treatment, and Control of High Blood Pressure: A Population-Based Survey in Thai Nguyen, Vietnam. PLoS ONE. Internet]. 2013;8. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L369208860/U2-L369208860
  • Ha NT, Duy HT, Le NH, et al. Quality of life among people living with hypertension in a rural Vietnam community. BMC Public Health. 2014;14:833.
  • Do HT, Geleijnse JM, Le MB, et al. National prevalence and associated risk factors of hypertension and prehypertension among Vietnamese adults. Am J Hypertens. 2015;28:89–97.
  • Nguyen TPL, Krabbe PF, Nguyen TB, et al. Utilities of Patients with Hypertension in Northern Vietnam. PLoS ONE. 2015;10:e0139560–e0139560.
  • Nguyen T-P-L, Schuiling-Veninga CCM, Nguyen TBY, et al. Adherence to hypertension medication: quantitative and qualitative investigations in a rural Northern Vietnamese community. PLOS ONE. 2017;12:e0171203.
  • Veith D, Fitzpatrick A, Tam T. Understanding the challenges for treatment of hypertension in rural Vietnam. J Investig Med. 2016;64:169.
  • Nguyen QN, Pham ST, Nguyen VL, et al. Time Trends in Blood Pressure, Body Mass Index and Smoking in the Vietnamese Population: A Meta-Analysis from Multiple Cross-Sectional Surveys. Plos One. Internet]. 2012;7:e42825. Available from: WOS:000307378500028.
  • Nguyen QN, Pham ST, Nguyen VL, et al. Implementing a hypertension management programme in a rural area: local approaches and experiences from Ba-Vi district, Vietnam. BMC Public Health. 2011;11:325.
  • Nguyen QN, Pham ST, Nguyen VL, et al. Effectiveness of community-based comprehensive healthy lifestyle promotion on cardiovascular disease risk factors in a rural Vietnamese population: a quasi-experimental study. BMC Cardiovasc Disord. 2012;12:56.
  • Lim J, Chan MM, Alsagoff FZ, et al. Innovations in non-communicable diseases management in ASEAN: a case series. Glob Health Action. 2014;7:25110.
  • Harper C. Vietnam noncommunicable disease prevention and control program 2002–2010: implementation review. Hanoi: World Health Organization; 2011.
  • One Plan 2012–2016 [Internet]. Hanoi: The Government of the Socialist Republic of Viet Nam & The United Nations in Viet Nam; 2012. Available from: http://www.un.org.vn/en/publications/cat_view/106-one-un-documents/119-one-plan.html
  • Arbulu A, Lindstrom J, Pham QN, et al. Independent Review of the One Plan (2012–2016) Between the Government of the Socialist Republic of Viet Nam and the United Nations in Viet Nam [Internet]. SIPU; 2016. Available from: http://www.un.org.vn/en/publications/cat_view/106-one-un-documents/119-one-plan.html.
  • Vietnam MoH. Roadmap: to develop and implement the basic health service package paid by health insurance in Vietnam. Hanoi: Vietnam Ministry of Health; 2015.
  • Joint Annual Health Review. 2011: strengthening Management Capacity and Reforming Health Financing to Implement the Five-year Health Sector Plan 2011–2015. Hanoi: Vietnam Ministry of Health & Health Partnership Group; 2011.
  • Hoang VM, Soonthornthada K, Ng N, et al. Blood pressure in adult rural INDEPTH population in Asia. Glob Health Action. 2009;2:60–67.
  • Ministry of Health. National Survey on the Risk Factors of Non-Communicable Diseases (STEPS) Viet Nam, 2015. Hanoi: Vietnam Ministry of Health; 2016.
  • Son PT. Hypertension in Vietnam: from community-based studies to a national target programme [Internet]. Sweden: Umeå University; 2013. ( Available from: urn: nbn:se:umu:diva-55175).
  • Joint Annual Health Review. 2013: Towards Universal Health Coverage. Hanoi: Vietnam Ministry of Health & Health Partnership Group; 2013.
  • Vietnam MoH. National Survey on The Risk Factors of Non-Communicable Diseases (STEPS) Viet Nam. Hanoi: Vietnam Ministry of Health; 2016.
  • Nguyen TPL. 2016. Health economics of screening for hypertension in Vietnam [Internet]. The Netherlands: University of Groningen. Available from: http://hdl.handle.net/11370/a17b9852-6eed-4b9d-b7ff-4e71932b04cd
  • Hoang VM. Epidemiology of cardiovascular disease in rural Vietnam [Internet]. Sweden: Umeå University; 2006. ( Available from: urn: nbn:se:umu:diva-779).
  • Guidelines for Diagnosis, Treatment, Prevention of Hypertension. Vietnamese Society of Hypertension & Vietnam Heart Association; 2014.
  • Joint Annual Health Review. 2012: improving Quality of Medical Services. Hanoi: Vietnam Ministry of Health & Health Partnership Group; 2012.
  • Atun R, de Jongh TE, Secci FV, et al. Integration of priority population, health and nutrition interventions into health systems: systematic review. BMC Public Health. 2011;11:780.
  • Mills KT, Bundy JD, Kelly TN, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-based Studies from 90 Countries. Circulation. 2016;134:441–450.
  • Joshi R, Alim M, Kengne AP, et al. Task Shifting for Non-Communicable Disease Management in Low and Middle Income Countries – A Systematic Review. PLOS One. 2014;9:e103754.
  • Durão S, Ajumobi O, Kredo T, et al. Evidence insufficient to confirm the value of population screening for diabetes and hypertension in low- and-middle-income settings. South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 2015;105:98–102.
  • Campbell NRC, Berbari AE, Cloutier L, et al. Policy Statement of the World Hypertension League on Noninvasive Blood Pressure Measurement Devices and Blood Pressure Measurement in the Clinical or Community Setting. J Clin Hypertens. 2014;16:320–322.
  • Maurer J, Ramos A. One-Year Routine Opportunistic Screening for Hypertension in Formal Medical Settings and Potential Improvements in Hypertension Awareness Among Older Persons in Developing Countries: evidence From the Study on Global Ageing and Adult Health (SAGE). Am J Epidemiol. 2015;181:180–184.
  • Bhojani U, Mishra A, Amruthavalli S, et al. Constraints faced by urban poor in managing diabetes care: patients’ perspectives from South India. Glob Health Action. 2013;6:22258.
  • Goudge J, Gilson L, Russell S, et al. Affordability, availability and acceptability barriers to health care for the chronically ill: longitudinal case studies from South Africa. BMC Health Serv Res. 2009;9:75.
  • Nguyen HT, Luu TV, Leppert G, et al. Community preferences for a social health insurance benefit package: an exploratory study among the uninsured in Vietnam. BMJ Glob Health. Internet]. 2017;2:e000277. [cited 2018 May 2]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717949/
  • Ha D-A. Social Health Insurance as a Means to Achieving Universal Coverage and More Equitable Health Outcomes. Hanoi: UNICEF; 2011.
  • Nguyen Duc T. 2015. The impact of a health insurance program on the near-poor in Vietnam [Internet]. Australia: Queensland University of Technology. Available from: https://eprints.qut.edu.au/86081/
  • Samb B, Van Bolhuis A, Alwan A, et al. Chapter 4: improving disease management, Access – Delivering Universal Primary Care Services for Non-communicable Diseases: the Need for Stronger Country Health Systems [Internet]. Commonwealth Health Ministers’ Update; 2011 [cited 2018 Feb 5]. Available from: http://apps.who.int/medicinedocs/documents/s18644en/s18644en.pdf.
  • Vázquez TR, Ghebreyesus TA. Beating NCDs can help deliver universal health coverage. Lancet. 2017;390:1473–1474.
  • Maher D, Ford N, Unwin N. Priorities for developing countries in the global response to non-communicable diseases. Glob Health. 2012;8:14.
  • Meiqari L, Al-Oudat T, Essink D, et al. How have researchers defined and used the concept of ‘continuity of care’ for chronic conditions in the context of resource-constrained settings? A scoping review of existing literature and a proposed conceptual framework. Health Research Policy and Systems. 2019;17:27.
  • Rabkin M, El-Sadr WM. Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases. Glob Public Health. 2011;6:247–256.
  • Rabkin M, Kruk ME, El-Sadr WM. HIV, aging and continuity care: strengthening health systems to support services for noncommunicable diseases in low-income countries. AIDS Lond Engl. 2012;26:S77–S83.
  • Abdel-All M, Putica B, Praveen D, et al. Effectiveness of community health worker training programmes for cardiovascular disease management in low-income and middle-income countries: a systematic review. BMJ Open. 2017;7:e015529.
  • Seidman G, Atun R. Does task shifting yield cost savings and improve efficiency for health systems? A systematic review of evidence from low-income and middle-income countries. Hum Resour Health. 2017;15:29.
  • Michael D, Kezakubi D, Juma A, et al. The feasibility and acceptability of screening for hypertension in private drug retail outlets: a pilot study in Mwanza region, Tanzania. Int Health. 2016;8:360–366.
  • Puspitasari HP, Aslani P, Krass I. Challenges in the management of chronic noncommunicable diseases by Indonesian community pharmacists. Pharm Pract. 2015;13:578.
  • La Torre G, Backhaus I, Mannocci A. Rating for narrative reviews: concept and development of the International Narrative Systematic Assessment tool. Senses Sci. 2015;2(2):31–35. doi:10.14616/sands-2015-2-3135